Coherus Oncology (CHRS) Exchange Rate Effect (2014 - 2019)
Coherus Oncology's (CHRS) quarterly Exchange Rate Effect came in at -$106000.0 in Q4 2019, down 176.81% year-over-year from $138000.0 in Q4 2018, and down 279.66% quarter-over-quarter from $59000.0 in Q3 2019.
Powered by 
Analysis
Coherus Oncology (CHRS) Exchange Rate Effect (2014 - 2019) Analysis & Trends
Coherus Oncology has disclosed Exchange Rate Effect across 6 years of filings, most recently posting -$106000.0 for Q4 2019.
- In Q4 2019, Exchange Rate Effect fell 176.81% year-over-year to -$106000.0; the TTM figure through Mar 2020 stood at -$140000.0 (down 140.58% YoY), while the FY2019 annual figure was -$276000.0, down 158.97% from the prior year.
- Exchange Rate Effect came in at -$106000.0 for Q4 2019 at Coherus Oncology, down from $59000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $226000.0 in Q2 2018 to a low of -$271000.0 in Q4 2016.
- Average Exchange Rate Effect over 5 years is -$12100.0, with a median of -$28000.0 recorded in 2015.
- Year-over-year, Exchange Rate Effect surged 2071.43% in 2018 and plunged 946.15% in 2019.
- Over 5 years, Exchange Rate Effect stood at $82000.0 in 2015, then slumped by 430.49% to -$271000.0 in 2016, then surged by 97.42% to -$7000.0 in 2017, then surged by 2071.43% to $138000.0 in 2018, then slumped by 176.81% to -$106000.0 in 2019.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$106000.0 in Q4 2019, $59000.0 in Q3 2019, and -$93000.0 in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | Coherus Oncology | 209.00 Mn | 103.70 Mn | 10.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | -106,000.00 |
| Sep 30, 2019 | 59,000.00 |
| Jun 30, 2019 | -93,000.00 |
| Mar 31, 2019 | -136,000.00 |
| Dec 31, 2018 | 138,000.00 |
| Sep 30, 2018 | 117,000.00 |
| Jun 30, 2018 | 226,000.00 |
| Mar 31, 2018 | -13,000.00 |
| Dec 31, 2017 | -7,000.00 |
| Sep 30, 2017 | -70,000.00 |
| Jun 30, 2017 | 122,000.00 |
| Mar 31, 2017 | -165,000.00 |
| Dec 31, 2016 | -271,000.00 |
| Sep 30, 2016 | -45,000.00 |
| Jun 30, 2016 | -35,000.00 |
| Mar 31, 2016 | -47,000.00 |
| Dec 31, 2015 | 82,000.00 |
| Sep 30, 2015 | -21,000.00 |
| Jun 30, 2015 | 175,000.00 |
| Mar 31, 2015 | -152,000.00 |